Do hormonal contraceptives stimulates growth of neurofibromas? A survey on 59 NFI patients

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Lammert, Marge ^a   Mautner, Victor Felix ^a   Kluwe, Lan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEPOT CLINOVIR; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS LYNESTRENOL; FEMRANETTE; MEDROXYPROGESTERONE ACETATE; MEDROXYPROGESTERONE ACETATE PLUS NORETHISTERONE ENANTATE; NON OVLON; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROGESTERONE RECEPTOR; TRISISTON; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; DRUG MEGADOSE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; NEUROFIBROMA; NEUROFIBROMATOSIS; PERIPHERAL NERVE TUMOR; PREGNANCY; PUBERTY; RECEPTOR UPREGULATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; ADOLESCENT; ADULT; AGED; CHEMICALLY INDUCED DISORDER; HEALTH SURVEY; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HEALTH SURVEYS; HUMANS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; NEUROFIBROMATOSIS 1; PROGESTERONE;

EID: 26244441343     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-16     Document Type: Article

References (3)

1. Huson SM: Neurofibromatosis: historical perspective, classification and diagnostic criteria. In neurofibromatoses Edited by: Huson SM, Hughes RA, London, Cahpman & Hall Medical; 1994: 11-12.
2. McLaughlin EM, Jacks T: Progesterone receptor expression in neurofibromas. Cancer Res 2003, 63:752-755.
3. Gutmann D, Aylsworth A, Carey J, Korf B, Marks J, Pyeritz R, Rubenstein A, Viskochil D: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997, 278:51-57.